• ProQR licenses Ionis’ RNA drug for inherited blindness fiercebiotech
    November 02, 2018
    ProQR is licensing an RNA medicine from Ionis Pharmaceuticals for the treatment of retinitis pigmentosa, a form of rare, inherited blindness. The plan is to start a phase 1/2 trial of... 
PharmaSources Customer Service